Wen‐Yi Shau

5.2k total citations · 1 hit paper
94 papers, 3.9k citations indexed

About

Wen‐Yi Shau is a scholar working on Epidemiology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wen‐Yi Shau has authored 94 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 22 papers in Surgery and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wen‐Yi Shau's work include Hepatitis B Virus Studies (9 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis C virus research (8 papers). Wen‐Yi Shau is often cited by papers focused on Hepatitis B Virus Studies (9 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis C virus research (8 papers). Wen‐Yi Shau collaborates with scholars based in Taiwan, United States and China. Wen‐Yi Shau's co-authors include Mei‐Shu Lai, Ding‐Shinn Chen, Mei‐Hwei Chang, Der‐Cherng Liang, Tzee‐Chung Wu, Chien‐Jen Chen, Hsu–Mei Hsu, Man‐Shan Kong, Chia‐Hsuin Chang and Day‐Yu Chao and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and Gastroenterology.

In The Last Decade

Wen‐Yi Shau

90 papers receiving 3.8k citations

Hit Papers

Universal Hepatitis B Vaccination in Taiwan and the Incid... 1997 2026 2006 2016 1997 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in Children
    1997 1.3k citations Mei‐Shu Lai, Wen‐Yi Shau et al. profile →

Peers

Wen‐Yi Shau
Yao‐Chun Hsu Taiwan
Shahin Merat Iran
Mario Pirisi Italy
Chien‐An Sun Taiwan
Davor Štimac Croatia
Arie Regev United States
Daniele Prati Italy
Tiejun Zhang China
J. D. Maxwell United Kingdom
Tim Card United Kingdom
Yao‐Chun Hsu Taiwan
Wen‐Yi Shau
Citations per year, relative to Wen‐Yi Shau Wen‐Yi Shau (= 1×) peers Yao‐Chun Hsu

Countries citing papers authored by Wen‐Yi Shau

Since Specialization
Citations

This map shows the geographic impact of Wen‐Yi Shau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Yi Shau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Yi Shau more than expected).

Fields of papers citing papers by Wen‐Yi Shau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Yi Shau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Yi Shau. The network helps show where Wen‐Yi Shau may publish in the future.

Co-authorship network of co-authors of Wen‐Yi Shau

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Yi Shau. A scholar is included among the top collaborators of Wen‐Yi Shau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Yi Shau. Wen‐Yi Shau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shau, Wen‐Yi, et al.. (2025). Risk factors for disease progression and clinical outcomes in patients with COVID-19 in Taiwan: a nationwide population-based cohort study. BMC Pulmonary Medicine. 25(1). 43–43. 2 indexed citations
2.
Shih, Jin‐Yuan, Yung‐Hung Luo, Gee‐Chen Chang, et al.. (2024). Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer. Journal of the Formosan Medical Association. 123(8). 875–881. 3 indexed citations
3.
Julian, Guilherme Silva, et al.. (2024). Bridging Real-World Data Gaps: Connecting Dots Across 10 Asian Countries. JMIR Medical Informatics. 12. e58548–e58548.
4.
Lin, Fang‐Ju, Kou‐Gi Shyu, Ching‐Lin Hsieh, et al.. (2020). Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70–100 mg/dL in Taiwan. Journal of the Formosan Medical Association. 119(5). 907–916. 5 indexed citations
5.
6.
Liao, Bin-Chi, Yu‐Yun Shao, Ho‐Min Chen, et al.. (2014). Comparative Effectiveness of First-Line Platinum-Based Chemotherapy Regimens for Advanced Lung Squamous Cell Carcinoma. Clinical Lung Cancer. 16(2). 137–143. 13 indexed citations
7.
Chang, Chwen‐Tzuei, Jenn‐Kuen Lee, Jen‐Der Lin, et al.. (2013). The lipid-lowering effect of atorvastatin in Taiwanese diabetic patients with hyperlipidemia. Tzu Chi Medical Journal. 25(3). 168–174. 1 indexed citations
8.
Shao, Yu‐Yun, Wen‐Yi Shau, Zhong‐Zhe Lin, et al.. (2012). Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer. European Journal of Cancer. 49(1). 106–114. 19 indexed citations
9.
Lu, Li‐Chun, Yu‐Yun Shao, Zhong‐Zhe Lin, et al.. (2012). Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma. Cancer. 119(6). 1210–1216. 17 indexed citations
10.
Kuo, Yu‐Hsuan, Zhong‐Zhe Lin, Yu‐Yun Shao, et al.. (2012). Survival of Patients with Small Cell Lung Carcinoma in Taiwan. Oncology. 82(1). 19–24. 24 indexed citations
11.
Lee, Pei‐Lin, Ming‐Tzer Lin, Tiffany Ting‐Fang Shih, et al.. (2011). CPAP effects on leptin and visceral fat in patients with sleep apnea: Double-blind, randomized, controlled trial. European Respiratory Journal. 38(Suppl 55). 1428–1428. 1 indexed citations
12.
Huang, John, Chia‐Hsuin Chang, Jiun‐Ling Wang, et al.. (2009). Nationwide epidemiological study of severe gallstone disease in Taiwan. BMC Gastroenterology. 9(1). 63–63. 49 indexed citations
13.
Fang, Chi‐Tai, Wen‐Yi Shau, Po‐Ren Hsueh, et al.. (2006). Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome. Journal of Antimicrobial Chemotherapy. 57(3). 511–519. 45 indexed citations
14.
Wang, Jann‐Yuan, Po‐Ren Hsueh, Yuang‐Shuang Liaw, et al.. (2005). Mycobacterium tuberculosis inducing disseminated intravascular coagulation. Thrombosis and Haemostasis. 93(4). 729–734. 28 indexed citations
15.
16.
Chen, Wei‐Li, Chung‐May Yang, Yufang Chen, et al.. (2002). CILIARY DETACHMENT AFTER PARS PLANA VITRECTOMY. Retina. 22(1). 53–58. 21 indexed citations
17.
Chao, Anne, Pei‐Kwei Tsay, Sheng‐Hsiang Lin, Wen‐Yi Shau, & Day‐Yu Chao. (2001). The applications of capture‐recapture models to epidemiological data. Statistics in Medicine. 20(20). 3123–3157. 261 indexed citations
18.
Lu, Tsung‐Hsueh, et al.. (2001). Factors associated with errors in death certificate completion. Journal of Clinical Epidemiology. 54(3). 232–238. 88 indexed citations
19.
Lin, Yu‐Tsan, Yao‐Hsu Yang, Po‐Nien Tsao, et al.. (2000). Comparison of serum specific IgE antibodies to staphylococcal enterotoxins between atopic children with and without atopic dermatitis. Allergy. 55(7). 641–646. 37 indexed citations
20.
Cheng, Wen‐Fang, Chien‐Nan Lee, Jan‐Show Chu, et al.. (1999). Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma. Cancer. 85(3). 651–657. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yao‐Chun Hsu Breakdown of academic impact, for papers by Shahin Merat Breakdown of academic impact, for papers by Mario Pirisi Breakdown of academic impact, for papers by Chien‐An Sun Breakdown of academic impact, for papers by Davor Štimac Breakdown of academic impact, for papers by Arie Regev Breakdown of academic impact, for papers by Daniele Prati Breakdown of academic impact, for papers by Tiejun Zhang Breakdown of academic impact, for papers by J. D. Maxwell Breakdown of academic impact, for papers by Tim Card
Rankless by CCL
2026